Edition:
United Kingdom

UDG Healthcare plc (UDG.L)

UDG.L on London Stock Exchange

664.00GBp
20 Sep 2018
Change (% chg)

-- (--)
Prev Close
664.00
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
893,804
52-wk High
963.00
52-wk Low
625.00

Latest Key Developments (Source: Significant Developments)

Udg Healthcare Names Nigel Clerkin As CFO
Tuesday, 19 Dec 2017 

Dec 19 (Reuters) - Udg Healthcare Plc ::CFO APPOINTMENT.‍CFO APPOINTMENT​.‍ANNOUNCE APPOINTMENT OF NIGEL CLERKIN AS CHIEF FINANCIAL OFFICER OF COMPANY​.‍NIGEL WILL START WITH COMPANY ON 1 MAY 2018 AND WILL REPLACE ALAN RALPH FROM THAT DATE​.‍ALAN WILL SUPPORT TRANSITION UNTIL HIS PREVIOUSLY ANNOUNCED RETIREMENT IN NOVEMBER 2018​.  Full Article

UDG Healthcare reports ‍FY net revenue growth of 12 pct to $1,028.5 mln​
Tuesday, 28 Nov 2017 

Nov 28 (Reuters) - UDG Healthcare Plc ::SAYS ‍FY NET REVENUE GROWTH OF 12% (16% ON A CONSTANT CURRENCY BASIS) TO $1,028.5 MILLION.​.‍ADJUSTED DILUTED EARNINGS PER SHARE FROM CONTINUING OPERATIONS INCREASED BY 17%​.‍NET REVENUE GROWTH OF 12% (16% ON A CONSTANT CURRENCY BASIS) TO $1,028.5 MILLION​.SAYS ‍HAS NOW REDEPLOYED OVER TWO THIRDS OF NET PROCEEDS FROM 2016 SALE OF UNITED DRUG SUPPLY CHAIN BUSINESS TO MCKESSON​.PROPOSED 7.5% INCREASE IN FINAL DIVIDEND TO $9.72C PER SHARE, YIELDING A FULL YEAR DIVIDEND INCREASE OF 7% TO $13.3C PER SHARE​.‍UDG HEALTHCARE CHIEF FINANCIAL OFFICER, ALAN RALPH, HAS INFORMED BOARD THAT HE INTENDS TO RETIRE FROM HIS ROLE BY END OF 2018​.‍GROUP EXPECTS ORGANIC GROWTH TO ACCELERATE DURING SECOND HALF OF YEAR​.FY ‍ADJUSTED OPERATING PROFIT GROWTH OF 12% (17% ON A CONSTANT CURRENCY BASIS) TO $129.3 MILLION​.  Full Article

UDG Healthcare ‍announces acquisition of US-based healthcare communications agency​
Thursday, 14 Sep 2017 

Sept 14 (Reuters) - UDG HEALTHCARE PLC ::‍ANNOUNCES ACQUISITION OF US-BASED HEALTHCARE COMMUNICATIONS AGENCY FOR UP TO $75.8M​.‍MICROMASS IS BEING ACQUIRED FOR AN INITIAL CONSIDERATION OF $63.8 MILLION, WITH AN ADDITIONAL CONSIDERATION OF UP TO $12 MILLION PAYABLE OVER NEXT THREE YEARS​.  Full Article

UDG Healthcare says Q3 revenue, profit ahead of last year
Thursday, 3 Aug 2017 

Aug 3 (Reuters) - UDG HEALTHCARE PLC :Q3 REVENUE AND ADJUSTED PROFIT BEFORE TAX AHEAD OF SAME QUARTER LAST YEAR​.‍GROUP REVENUE AND ADJUSTED PROFIT BEFORE TAX FOR NINE MONTHS TO 30 JUNE 2017 ARE IN LINE WITH EXPECTATIONS AND WELL AHEAD OF PRIOR YEAR​.  Full Article

UDG Healthcare acquires Cambridge Biomarketing
Monday, 17 Jul 2017 

July 17 (Reuters) - UDG Healthcare Plc ::Says acquisition of Cambridge Biomarketing LLC, a US-based healthcare communications business, for a total consideration of up to $35 mln.Cambridge Biomarketing is being acquired for an initial consideration of $30 mln, with additional consideration of up to $5 mln .  Full Article

UDG Healthcare ‍acquires Vynamic for up to $32 mln
Wednesday, 12 Jul 2017 

July 12 (Reuters) - Udg Healthcare Plc :‍Acquisition of Vynamic Llc, a US-based healthcare industry management consulting firm, for total consideration of up to $32 million​.Says ‍Vynamic is being acquired for an initial consideration of $22 million​.Says ‍additional consideration of up to $10 million payable over next three years, based on achievement of agreed profit targets​.Says ‍business has been acquired for an upfront multiple of c. 7X ebit​.‍Also received competition approval for acquisition of Sellxpert Gmbh for a total potential consideration of up to $14.4 million​.  Full Article

UDG Healthcare appoints Jez Moulding as group COO
Wednesday, 12 Apr 2017 

UDG Healthcare Plc :Appoints Jez Moulding as group chief operating officer and executive vice president of Ashfield.  Full Article

UDG Healthcare division Sharp expands capacity in the US, UK
Monday, 3 Apr 2017 

UDG Healthcare Plc :Sharp Packaging Services, a division of UDG Healthcare Plc, announces capacity expansion in US and UK.  Full Article

UDS Healthcare says has made a good start to financial year
Tuesday, 7 Feb 2017 

UDG Healthcare Plc : 1St quarter trading update . Good start to year and full year guidance issued . Group has made a good start to financial year with operating profits for quarter to 31 december 2016 well ahead of same quarter last year . Performance has been driven by continued good underlying growth and impact of acquisitions . As a result of fall in value of sterling, reported profit growth was moderated by translation of our sterling profits into us dollars. .Expects constant currency adjusted diluted eps 1 for year to 30 sept 2017 to be between 13% and 16% ahead of last year's continuing group eps of us$ 31.8c (euro: 28.6c)..  Full Article

Photo

European stocks falter as pharma sector falls

LONDON European shares dipped on Wednesday as poor corporate earnings in the pharmaceutical sector weighed on sentiment already soured by trade tensions, with Washington preparing tariffs on another $16 billion (12.4 billion pounds) of Chinese goods.

No consensus analysis data available.